Synergistic Li/Li Bimetallic System for the Asymmetric Synthesis of Antituberculosis Drug TBAJ-587

Tanveer Ahmad, Feng Gao, Jing Li, Zhenfeng Zhang, Tao Song, Qianjia Yuan, Wanbin ZhangThe Journal of Organic Chemistry 2023 · DOI

TL;DR

Researchers have developed the first asymmetric synthesis of TBAJ-587, a promising new antituberculosis drug candidate. This novel method utilizes a synergistic Li/Li bimetallic system, achieving high yields and excellent enantioselectivity, even on a gram scale, paving the way for efficient clinical drug production.

What Problem Does This Paper Address?

Tuberculosis (TB) remains a significant global health threat, with the rise of drug-resistant strains necessitating the development of new, effective treatments. TBAJ-587, a derivative of the approved drug bedaquiline (BDQ), shows comparable potency against Mycobacterium tuberculosis but with improved toxicity and pharmacokinetic profiles, making it a promising candidate for clinical trials. However, a major hurdle has been the lack of an efficient and reproducible synthetic route for TBAJ-587, particularly for its stereochemically pure form. The molecule contains challenging vicinal stereocenters, including a chiral tertiary alcohol, which are notoriously difficult to construct enantioselectively. Previous attempts yielded only racemic mixtures with poor reproducibility, hindering its progression towards large-scale production.

Methods

The core innovation presented is a synergistic Li/Li bimetallic system for the asymmetric synthesis of TBAJ-587. This approach leverages the unique reactivity of two lithium centers working in concert. The reaction involves the nucleophilic addition of a quinoline derivative (1) to an aryl ketone (2).

Key aspects of the methodology include:

  • Bimetallic Activation: Two distinct lithium complexes are formed, one activating the nucleophile and the other the electrophile, leading to synergistic activation and promoting the addition reaction.
  • Ligand Optimization: A library of chiral ligands was screened to identify optimal combinations that control enantioselectivity. The study highlights the importance of specific chiral ligands (like L4) and achiral additives.
  • Additive Use: The addition of 4 Å molecular sieves was found to be crucial for significantly improving both yield and enantioselectivity.
  • Gram-Scale Synthesis: The developed protocol was successfully scaled up to 5 grams, demonstrating its practical applicability.
  • Simple Purification: A straightforward recrystallization method was employed to achieve very high enantiomeric purity (99.9:0.1 er) from the initially obtained product.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • Synergistic Bimetallic Catalysis for Complex Targets: The paper demonstrates that a synergistic Li/Li bimetallic system, previously explored for related compounds, can be successfully adapted and optimized for the challenging synthesis of TBAJ-587, overcoming specific coordination complexities.
  • The Power of Molecular Sieves: The unexpected but significant improvement in enantioselectivity and yield upon adding 4 Å molecular sieves suggests a role beyond simple water scavenging, potentially influencing the aggregation state or coordination environment of the lithium species.
  • Efficient Purification Strategy: The ability to achieve near-perfect enantiomeric purity through a simple recrystallization step after the initial synthesis is a major practical advantage, greatly simplifying downstream processing for drug manufacturing.
  • Ligand Design and Optimization: The systematic screening and optimization of ligands underscore the critical role of ligand choice in directing stereoselectivity in complex organometallic reactions.

Key Results

  • High Yield and Enantioselectivity: The optimized reaction achieved a 90% yield and an 80:20 enantiomeric ratio (er) on a 5 g scale.
  • Exceptional Purity: After a simple recrystallization, the product was obtained with an outstanding 99.9:0.1 er.
  • Improved Diastereoselectivity: The reaction also provided a good diastereomeric ratio (dr) of 1:1, which was further improved to 5:1 after recrystallization.
  • Previous Method Comparison: The new protocol significantly outperforms the prior method, which yielded only 52% of an isomeric mixture with no enantioselectivity and poor reproducibility.

Limitations and Future Work

  • Mechanism Elucidation: While a proposed mechanism is presented (Scheme 2), further detailed mechanistic studies could provide deeper insights into the synergistic activation and the role of additives.
  • Ligand Scope: While a successful ligand (L4) was identified, exploring a broader range of chiral ligands might uncover even more efficient or selective systems.
  • Broader Applicability: The authors suggest that this synergistic Li/Li bimetallic system could be a valuable tool for the asymmetric synthesis of other complex molecules with similar structural features.

The successful development of this efficient and scalable asymmetric synthesis of TBAJ-587 is a significant step forward, greatly facilitating its potential clinical development and eventual availability as a treatment for tuberculosis.

Summary updated

Abstract

TBAJ-587, an analogue of the antituberculosis drug bedaquiline (BDQ), bearing a diarylquinoline skeleton retains the high bacterial potency, is less toxic, and has a better pharmacokinetic profile than the parent molecule, which has entered phase I clinical trials. In contrast to its fascinating bioactivity, however, the highly efficient synthesis of this molecule is still an unsolved challenge. Herein, the first asymmetric synthesis of TBAJ-587 based on a synergistic Li/Li bimetallic system is reported. The product could be obtained in an excellent yield of 90% and an enantiomeric ratio (er) of 80:20. Furthermore, the reaction could be conducted on a 5 g scale, and the product was obtained with 99.9:0.1 er after a simple recrystallization. The realization of this protocol will greatly aid the demand for clinical drug production.
BibTeX
@article{ahmad2023synergistic,
  author = {Tanveer Ahmad and Feng Gao and Jing Li and Zhenfeng Zhang and Tao Song and Qianjia Yuan and Wanbin Zhang},
  title = {{Synergistic Li/Li Bimetallic System for the Asymmetric Synthesis of Antituberculosis Drug TBAJ-587}},
  journal = {The Journal of Organic Chemistry},
  year = {2023},
  doi = {10.1021/acs.joc.3c00705},
}
Figure